Evidence map›Paper›PMID 42742576›Full record

ArticleWorld psychiatry : official journal of the World Psychiatric Association (WPA)2026

An etiological approach to psychosis: potential benefits for treatment, research and prevention.

Robin M Murray, Dominic Oliver, Aikaterini Dima, Luis Alameda

Abstract read
In one paragraph

Article in World psychiatry : official journal of the World Psychiatric Association (WPA), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Robin M MurrayDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Dominic OliverDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Aikaterini DimaDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Luis AlamedaDepartment of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current treatment of psychosis focuses on antipsychotic medication, and rarely addresses the factors that have contributed to the onset and persistence of the disorder. We suggest that the most useful way of facilitating treatment, research and prevention is to identify the causal risk factors to which psychotic patients have been exposed. Operating on a background of genetic vulnerability, the main types of environmental risk factors for psychosis comprise impaired neurodevelopment, substance abuse, and social adversity. In most patients with psychosis, striatal dopamine dysfunction, often mediated by disrupted gamma-aminobutyric acid (GABA)ergic and glutamatergic signaling in the hippocampus, appears to be the final common pathway from those distal risk factors to positive symptoms. There are clinical and biological differences among individuals who develop psychosis following exposure to the different risk factors. For example, those with impaired neurodevelopment are more likely to show minor physical anomalies or soft neurological signs, cognitive deficits, and brain structural abnormalities. Individualized interventions need to be offered to those patients who have been exposed to particular risk factors. For example, in addition to antipsychotic medication, patients who continue to use cannabis should be offered cognitive behavioral/motivational therapy to decrease their substance consumption, while patients who were exposed to child abuse could be offered trauma-based therapy, and antidepressants as appropriate. Of course, many patients have been exposed to more than one type of risk factor. Such patients deserve therapeutic action directed to each of those risk pathways. In addition to promoting individualized treatment, attention to etiology could benefit research, allowing the study of psychological and biological characteristics of patients whose psychosis appears to have resulted predominantly from one particular risk factor, and could open the door to universal and selective preventive strategies to decrease psychosis incidence through reducing exposure to risk factors.

Indexed as

environmental risk factorsgenetic vulnerabilityindividualized interventionsneurodevelopmental impairmentpreventive strategiesPsychosissocial adversitystriatal dopamine dysfunctionsubstance abuse

Identifiers

PMID42742576
PMCPMC13576979

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.